Metraipolis › archive › dc_aab11640ef78
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression — Europe PMC PMID:41564176
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41564176
- DOI
- 10.1126/sciadv.adz9227
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:09:58.617Z
- SHA-256 of the archived text
70b7d3974da5281fc2bd467602bcea8351d82dd044ef449146264071562927df- Stable URL of this page
https://metraipolis.com/documento/dc_aab11640ef78
How to cite
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression — Europe PMC PMID:41564176 — Europe PMC (en), https://europepmc.org/article/MED/41564176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aab11640ef78 (Metraipolis archive dc_aab11640ef78, sha256 70b7d3974da5281fc2bd467602bcea8351d82dd044ef449146264071562927df)
BibTeX
@misc{dcaab11640ef78,
title = {Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression — Europe PMC PMID:41564176},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41564176},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aab11640ef78; sha256 70b7d3974da5281fc2bd467602bcea8351d82dd044ef449146264071562927df},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41564176. Agents can read the archived copy with the MCP tool read_document.